NON-Invasive Examinations of Coronary Artery Disease

Coronary Artery Disease Clinical Trial

— NONCAD  

Official title:

NON-Invasive Examinations of Coronary Artery Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00926458
• Other study ID #: NONCAD
• Status: Recruiting
• Phase: N/A
• First received: June 22, 2009
• Last updated: June 22, 2009
• Start date: January 2009
• Est. completion date: January 2012

Study information

• Verified date: June 2009
• Source: Herning Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: Danish Dataprotection Agency
• Study type: Observational

Clinical Trial Summary

The aim of the study is to evaluate and compare the value of 5 different non-invasive diagnostic methods in patients with chest pain suspected for coronary artery disease. The investigators intend to include 200 patients over a 3 year period in the study. The participants will be recruited from patients referred to coronary angiography at the institution. Before the angiography the participants will (1) test the effect of sublingual Nitroglycerin, (2) give their medical history so mathematical models can estimate the probability of the presence of coronary artery disease, (3) take part in a contrast stress echocardiography and (4) a 2D-strain stress echocardiography and a myocardial scintigraphy. Stenosis found at the angiography will be the gold standard.

Description:

The aim of the study is to evaluate the diagnostic value of various non-invasive methods. The study is divided into five substudies:

Substudy NITRO

Purpose: To investigate whether a subjective effect of Nitroglycerine is associated with significantly narrowed coronary arteries.

The participants are instructed to alternate between rest and Nitroglycerine as treatment for chest pain attacks during a 2 week period. Chest pain score is recorded in a diary handed out at day 1 together with 30 tablets Nitroglycerine in the maximal tolerated dose.

Substudy SCORE

Aim: To test and compare the ability of different statistical methods using clinical data to predict the presence of narrowed coronary arteries in a contemporary Danish population.

Substudy CONTRAST

Aim: To evaluate if the blood flow in an area in the heart muscle measured by contrast adenosine stress echocardiography can predict the presence of significant stenosis in the coronary artery supplying the area.

Substudy 2D strain

Aim: To Evaluate if lack of increase in 2D strain during adenosine stress echocardiography can predict the presence of narrowed coronary arteries.

Substudy SPECT

Aim: To evaluate whether the result of a myocardial scintigraphy can predict symptomatic chest pain relief 6 months after a coronary angiography and possible treatment with balloon or bypass surgery.

Participants: Annually around 1,500 coronary angiographies are performed at Region Hospital Herning. We intend to include 200 patients referred by their physicians to coronary angiography in the study and expect the data collection phase to last 3 years.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: January 2012
• Est. primary completion date: January 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Intermittent episodes of chest pain (more than two attacks, minimum one attack/week)

2. Signed written informed consent

3. Sinus rhythm (ECG)

4. Age above 18 years

Exclusion Criteria:

1. Previously (known) myocardial infarction or unstable angina with dynamic changes in the ECG or biomarkers (serology)

2. CA performed earlier in life

3. Known significant cardiac valve disease

4. Asthma (not COPD)

5. Incapable of performing an exercise test

6. Malignant Disease

7. Senile dementia or other conditions causing impaired cooperation

8. Previous participation in the project

9. NTG intolerance

10. Pregnancy

11. Bundle branch block (QRS > 120 ms)

12. ECG changes:

• Pathologic Q-wave in at least two leads:

• QS-complex or Q-wave > 0.02 sec. in V2-V3

• QS-complex or Q-wave > 0.03 sec. and > 0.1 mV in I, II, aVL, aVF or V4-V6

• Pathologic negative T-wave (in V3-6 and I, II) unless this is part of a left ventricular hypertrophy and strain pattern

13. Brady pacemaker

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Disease
• Myocardial Ischemia

Locations

Country	Name	City	State
Denmark	Cardiovascular Research Unit, Regionhospital Herning	Herning

Sponsors (1)

Lead Sponsor	Collaborator
Herning Hospital

Country where clinical trial is conducted

Denmark,